# Cost Readiness Requirements Checklist: Live Demo Cost Readiness

**Purpose**: Reviewer-owned validation that the readiness, costing, live-freshness and
failure requirements are precise enough for implementation
**Created**: 2026-09-22
**Feature**: [spec.md](../spec.md)

`[x]` means a reviewer approved the quality of the written requirement. It does not
mean implementation is complete. `$speckit-implement` does not change these markers.

## Coverage and authority

- [ ] CHK001 Is the complete initial coverage set defined without relying on human item or document references? [Completeness, Spec §FR-001, §DR-003]
- [ ] CHK002 Is the distinction between received acquisition evidence, retained review judgment and disposable cost observation explicit? [Clarity, Spec §DR-001–DR-002]
- [ ] CHK003 Are positive-stock, zero-stock, zero-cost and evidence-missing cases distinguished without an ambiguous numeric fallback? [Consistency, Spec §FR-002, §FR-010, Edge Cases]
- [ ] CHK004 Are contribution eligibility and the meaning of “profile claims contribution coverage” sufficiently bounded for an objective census? [Clarity, Spec §FR-001, §FR-004]

## Setup lifecycle

- [ ] CHK005 Are the conditions for entering and leaving each setup calculation state documented, including terminal failure? [Completeness, Spec §FR-003–FR-006]
- [ ] CHK006 Is the ordering between profile seeding, verified cutoff, live-source start and ready publication unambiguous? [Consistency, Spec §FR-006]
- [ ] CHK007 Are retry and replay requirements defined for failure before and after the durable completion marker? [Coverage, Spec §FR-012, Edge Cases]
- [ ] CHK008 Is “visible long enough to be understood” objectively specified or delegated to an existing approved UI contract? [Ambiguity, Spec §FR-005]

## Continuous freshness

- [ ] CHK009 Are relevant events defined tightly enough to prevent both missed and full-company invalidation? [Clarity, Spec §FR-007]
- [ ] CHK010 Are ordinary live intake, relevant movements and selling-cost withdrawal distinguished without inventing replacement authority? [Coverage, Spec §FR-008, Edge Cases]
- [ ] CHK011 Is normal live-cycle freshness objectively separated from explicitly stale changed evidence? [Measurability, Spec §FR-009, §SC-003]
- [ ] CHK012 Are the meanings of current, updating, failed, stale and evidence-missing mutually exclusive at read time? [Consistency, Spec §FR-010]

## Failure, security and parity

- [ ] CHK013 Are bounded diagnostics specified without leaking foreign tenant identity or unbounded evidence payloads? [Security, Spec §FR-014, §DR-006]
- [ ] CHK014 Are cross-interface parity fields and unavailable-result semantics complete for every supported interface? [Completeness, Spec §FR-011, US3]
- [ ] CHK015 Is historical no-repair behavior consistent with rollout, rollback and any future explicit repair action? [Consistency, Spec §FR-013]
- [ ] CHK016 Does relevant evidence change preserve historical results while withholding an invalid current value? [Recovery, Spec US2 scenario 4, Edge Cases]

## Acceptance and traceability

- [ ] CHK017 Can every FR and DR be traced to an acceptance scenario and an executable proof without circular reliance on the readiness summary? [Traceability, Spec §SC-007]
- [ ] CHK018 Are the ten-run, six-sample and latency success criteria specific about selection, workload and pass/fail aggregation? [Measurability, Spec §SC-001–SC-003]
- [ ] CHK019 Are all non-goals consistent with the planned use of shared retained reviews, generations and scheduled jobs? [Consistency, Spec §Non-Goals, Plan §Design]
- [ ] CHK020 Are assumptions about the canonical profile, supported costing policies and normal Demo Data intake explicitly identified as dependencies rather than new authority? [Assumption, Spec §Assumptions and Dependencies]

## Review

- **Specification reviewer**: Product owner / 2026-09-22
- **Domain/architecture reviewer**: Pending
- **Decision**: Draft
